Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice

被引:101
作者
Han, Junyan [1 ]
Zhong, Jinxin [1 ]
Wei, Wenzhong [1 ]
Wang, Ying [1 ]
Huang, Yafei [1 ]
Yang, Ping [1 ]
Purohit, Sharad [1 ]
Dong, Zheng [2 ]
Wang, Mong-Heng [3 ]
She, Jin-Xiong [1 ]
Gong, Feili [4 ]
Stern, David M. [5 ]
Wang, Cong-Yi [1 ]
机构
[1] Med Coll Georgia, Dept Pathol, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA
[3] Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China
[5] Univ Cincinnati, Coll Med, Cincinnati, OH USA
关键词
D O I
10.2337/db07-1499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-The implication of innate immunity in type 1 diabetes development has long been proposed. High-mobility group box 1 (HMGB1), an evolutionarily conserved chromosomal protein, was recently recognized to be a potent innate inflammatory mediator when released extracellularly. We sought to test the hypothesis that HMGB1 acts as an innate immune mediator implicated in type I diabetes pathogenesis. RESEARCH DESIGN AND METHODS-Eight- and 12-week-old NOD mice were treated with an HMGB1 neutralizing antibody once a week until 25 weeks of age and monitored for insulitis progression and diabetes onset. The underlying mechanisms of HMGB1 regulation of autoimmune response were further explored. RESULTS-During autoimmunity, HMGB1 can be passively released from damaged pancreatic P-cells and actively secreted by islet infiltrated immune cells. Extracellular HMGB1 is potent in inducing NOD dendritic cell maturation and stimulating macrophage activation. Blockade of HMGB1 significantly inhibited insulitis progression and diabetes development in both 8- and 12-week-old NOD mice. HMGB1 antibody treatment decreased the number and maturation of pancreatic lymph node (PLN) CD11c(++)CD11b(+) dendritic cells, a subset of dendritic cells probably associated with autoantigen presentation to naive T- cells, but increased the number for PLN CD4(+)Foxp3(+) regulatory T-cells. Blockade of HMGB1 also decreased splenic dendritic cell allo-stimulatory capability associated with increased tolergenic CD11c(+)CD8a(+) dendritic cells. Interestingly, the number of CD8(+)interferon-gamma(+) (Tc1) T-cells was increased in the PLNs and spleen after blockade of HMGB1, which could be associated with retarded migration of activated autoreactive T-cells into the pancreatic islets. CONCLUSIONS-Extracellular HMGB1 functions as a potent innate immune mediator contributing to insulitis progression and diabetes onset.
引用
收藏
页码:2118 / 2127
页数:10
相关论文
共 41 条
  • [1] HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis
    Andersson, U
    Tracey, KJ
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (03) : 627 - +
  • [2] Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
    Andre, I
    Gonzalez, A
    Wang, B
    Katz, J
    Benoist, C
    Mathis, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2260 - 2263
  • [3] The role of innate immunity in autoimmunity
    Bach, JF
    Bendelac, A
    Brenner, MB
    Cantor, H
    De Libero, G
    Kronenberg, M
    Lanier, LL
    Raulet, DH
    Shlomchik, MJ
    von Herrath, MG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (12) : 1527 - 1531
  • [4] On the role of the innate immunity in autoimmune disease
    Bachmann, MF
    Kopf, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (12) : F47 - F50
  • [5] Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus
    Barkauskaite, V.
    Ek, M.
    Popovic, K.
    Harris, H. E.
    Wahren-Herlenius, M.
    Nyberg, F.
    [J]. LUPUS, 2007, 16 (10) : 794 - 802
  • [6] The extracellular release of HMGB1 during apoptotic cell death
    Bell, Charles W.
    Jiang, Weiwen
    Reich, Charles F., III
    Pisetsky, David S.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (06): : C1318 - C1325
  • [7] A role for innate immunity in type 1 diabetes?
    Beyan, H
    Buckley, LR
    Yousaf, N
    Londei, M
    Leslie, R
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (02) : 89 - 100
  • [8] SPECIFIC RECOGNITION OF CRUCIFORM DNA BY NUCLEAR-PROTEIN HMG1
    BIANCHI, ME
    BELTRAME, M
    PAONESSA, G
    [J]. SCIENCE, 1989, 243 (4894) : 1056 - 1059
  • [9] Innate immunity in the etiopathology of autoimmunity
    Carroll, M
    [J]. NATURE IMMUNOLOGY, 2001, 2 (12) : 1089 - 1090
  • [10] Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
    Dumitriu, IE
    Baruah, P
    Valentinis, B
    Voll, RE
    Herrmann, M
    Nawroth, PP
    Arnold, B
    Bianchi, ME
    Manfredi, AA
    Rovere-Querini, P
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (12) : 7506 - 7515